Table 1.
Basic clinical features of 11 patients with low rectal adenocarcinoma.
| Parameters | n (%) |
|---|---|
| Sex | |
| Male | 8 (72.72) |
| Female | 3 (27.27) |
| Age, median (range) | 50 (32–74) |
| BMI (kg/m2), median (range) | 18.9 (15.5–22) |
| ASA | |
| ASA score 1 | 7 (63.63) |
| ASA score 2 | 4 (36.36) |
| Distance to anal Verge (mm), median (range) | 48 (20–70) |
| Tumor size (mm), media (range) | 31 (17–48) |
| AJCC clinical Stages | |
| Stage Ⅰ | 0 |
| Stage Ⅱ | 5 (45.45) |
| Stage Ⅲ | 6 (54.54) |
| Stage Ⅳ | 0 |
| Clinical N stage | |
| cN0 | 6 (54.54) |
| cN1 | 3 (18.18) |
| cN2 | 2 (27.27) |
| Neoadjuvant treatment | |
| Chemotherapy | 5 (45.45) |
| Radiation therapy | 0 |
| Radiation and chemotherapy | 5 (45.45) |
ASA: American Society of Anesthesiologists, BMI: body mass index, AJCC: the American Joint Committee on Cancer.